(Q36614954)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021720%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

Combination DNA plus protein HIV vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021720%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021720%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Shan Lu

series ordinal

1

1 reference

15 August 2017

21 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021720%20AND%20SRC:MED&resulttype=core&format=json

Seminars in Immunopathology

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021720%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021720%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

255-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021720%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021720%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00281-006-0028-1

20 December 2019

exact match

0 references

cites work

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00281-006-0028-1

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00281-006-0028-1

Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00281-006-0028-1

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

21 January 2018

1 reference

12 December 2020

Use of lentivirus-like particles alone and in combination with live vaccinia-virus-based vaccines

1 reference

12 December 2020

Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein

1 reference

12 December 2020

Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins

1 reference

12 December 2020

HIV-1: nature's master of disguise

1 reference

12 December 2020

1 reference

12 December 2020

Generation and analysis of vaccinia virus recombinants

1 reference

12 December 2020

A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques

1 reference

12 December 2020

Urgently needed: a filter for the HIV-1 vaccine pipeline

1 reference

12 December 2020

Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients

1 reference

12 December 2020

Antibody neutralization and escape by HIV-1

1 reference

12 December 2020

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

1 reference

12 December 2020

Application of the polyvalent approach to HIV-1 vaccine development

1 reference

12 December 2020

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

12 December 2020

Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding

1 reference

12 December 2020

HIV-1 Env glycoproteins from two series of primary isolates: replication phenotype and immunogenicity

1 reference

12 December 2020

Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma

1 reference

12 December 2020

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

12 December 2020

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region

1 reference

12 December 2020

Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d.

1 reference

12 December 2020

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

1 reference

12 December 2020

Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine

1 reference

12 December 2020

Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains

1 reference

12 December 2020

Neutralizing antibody responses to HIV-1 infection

1 reference

12 December 2020

HIV vaccine design and the neutralizing antibody problem

1 reference

12 December 2020

Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles

1 reference

12 December 2020

Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.

1 reference

12 December 2020

Antigen epitope-expressing cytokines for DNA immunization.

1 reference

12 December 2020

Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate

1 reference

12 December 2020

Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge

1 reference

12 December 2020

Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.

1 reference

12 December 2020

Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting

1 reference

12 December 2020

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

12 December 2020

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

12 December 2020

Diversity considerations in HIV-1 vaccine selection

1 reference

12 December 2020

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

12 December 2020

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

12 December 2020

Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers

1 reference

12 December 2020

Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques.

1 reference

12 December 2020

Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

1 reference

12 December 2020

Anti-HIV env immunities elicited by nucleic acid vaccines

1 reference

12 December 2020

Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1

1 reference

12 December 2020

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

12 December 2020

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

12 December 2020

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

12 December 2020

Early studies on DNA-based immunizations for measles virus

1 reference

12 December 2020

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

1 reference

12 December 2020

Immunization for Ebola virus infection

1 reference

12 December 2020

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

1 reference

12 December 2020

Identifying epitopes of HIV-1 that induce protective antibodies

1 reference

12 December 2020

Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions

1 reference

12 December 2020

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

12 December 2020

Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene

1 reference

12 December 2020

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

12 December 2020

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

1 reference

12 December 2020

Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.

1 reference

12 December 2020

Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

1 reference

12 December 2020

Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin

1 reference

12 December 2020

Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions

1 reference

12 December 2020

Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.

1 reference

12 December 2020

Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting

1 reference

12 December 2020

Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells

1 reference

12 December 2020

Fusion-competent vaccines: broad neutralization of primary isolates of HIV

1 reference

12 December 2020

DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model

1 reference

12 December 2020

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

12 December 2020

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

1 reference

12 December 2020

A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine

1 reference

12 December 2020

Candidate AIDS vaccines

1 reference

12 December 2020

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

12 December 2020

A role for carbohydrates in immune evasion in AIDS.

1 reference

12 December 2020

DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus

1 reference

12 December 2020

DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans

1 reference

12 December 2020

10.1007/S00281-006-0028-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021720%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference